163 related articles for article (PubMed ID: 20924796)
1. Analysis of prognostic factors and a proposed new classification for invasive papillary mucinous neoplasms.
Jang JY; Hwang DW; Kim MA; Kang MJ; Lim CS; Lee SE; Kim SW
Ann Surg Oncol; 2011 Mar; 18(3):644-50. PubMed ID: 20924796
[TBL] [Abstract][Full Text] [Related]
2. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
3. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
4. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
5. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
6. Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma.
Shimada K; Sakamoto Y; Sano T; Kosuge T; Hiraoka N
Pancreas; 2006 Apr; 32(3):281-7. PubMed ID: 16628084
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
[TBL] [Abstract][Full Text] [Related]
8. Cystic neoplasms of the pancreas.
Goldsmith JD
Am J Clin Pathol; 2003 Jun; 119 Suppl():S3-16. PubMed ID: 12951841
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas.
Furukawa T; Hatori T; Fujita I; Yamamoto M; Kobayashi M; Ohike N; Morohoshi T; Egawa S; Unno M; Takao S; Osako M; Yonezawa S; Mino-Kenudson M; Lauwers GY; Yamaguchi H; Ban S; Shimizu M
Gut; 2011 Apr; 60(4):509-16. PubMed ID: 21193453
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of invasive intraductal papillary mucinous neoplasm.
Longnecker DS; Klöppel G
Pancreas; 2008 Oct; 37(3):333; author reply 333-4. PubMed ID: 18815559
[No Abstract] [Full Text] [Related]
11. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
Takasu N; Kimura W; Moriya T; Hirai I; Takeshita A; Kamio Y; Nomura T
Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
[TBL] [Abstract][Full Text] [Related]
12. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN.
Yamaguchi K; Kanemitsu S; Hatori T; Maguchi H; Shimizu Y; Tada M; Nakagohri T; Hanada K; Osanai M; Noda Y; Nakaizumi A; Furukawa T; Ban S; Nobukawa B; Kato Y; Tanaka M
Pancreas; 2011 May; 40(4):571-80. PubMed ID: 21499212
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas.
Wada K; Kozarek RA; Traverso LW
Am J Surg; 2005 May; 189(5):632-6; discussion 637. PubMed ID: 15862510
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
Hibi Y; Fukushima N; Tsuchida A; Sofuni A; Itoi T; Moriyasu F; Mukai K; Aoki T
Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
[TBL] [Abstract][Full Text] [Related]
18. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
[TBL] [Abstract][Full Text] [Related]
19. Invasive IPMN and MCN: same organ, different outcomes?
Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S
Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175
[TBL] [Abstract][Full Text] [Related]
20. Invasive carcinoma derived from intraductal papillary mucinous carcinoma of the pancreas.
Nakagohri T; Konishi M; Inoue K; Tanizawa Y; Kinoshita T
Hepatogastroenterology; 2004; 51(59):1480-3. PubMed ID: 15362782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]